Table 3.
Materials 2 | Analyte | LOD | Linear Range/s | Ref. |
---|---|---|---|---|
β-CD/rGO | Ascorbic acid | 0.067 mM | 0.2–2 mM | [129] |
Dopamine | 0.017 μM | 0.05–50 μM | ||
Uric acid | 0.026 μM | 0.08–150 μM | ||
3DrGO/Fe3O4/HP-β-CD | Serotonin | 3.3 nM | 0.01–25 μM | [204] |
Dopamine | 6.7 nM | 0.02–25 μM | ||
Ascorbic acid | 3.3 μM | 10–350 μM | ||
β-CD/CQDs | Ascorbic acid | 0.14 μM | 4–220 μM | [205] |
Uric acid | 0.01 μM | 0.3–200 μM | ||
Trypophan | 0.16 μM | 5–270 μM | ||
Au/NF/β-CD/AuNPs | Dopamine | 0.6 nM | 0.05–280 μM | [159] |
MWCNT/β-CD | Dopamine | 6.7 μM | 0.01–0.08 mM | [206] |
GR/CD/Pt | Cysteine | 0.12 μM | 0.5–170 μM | [207] |
(CuO/β-CD/NF | Tyrosine | 0.0082 μM | 0.01–100 μM | [208] |
PDA-β-CD | Glycine | 0.2 μM | 0.20–70 μM | [209] |
Cysteine | 0.06 μM | 0.06–0.2 μM | ||
Tyrosine | 0.01 μM | 0.01–0.1 μM | ||
Phenylalanine | 0.2 μM | 0.20–10 μM |
2 Abbreviations: carbon quantum dots (CQDs); Nafion (NF); polydopamine (PDA).